 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
15 September 1994 | Volume 121 Issue 6 | Pages 400-408
Objective: To study the effects of a megestrol acetate liquid formulation (800 mg/d) on body weight, body composition, caloric intake, and mental outlook in patients with the acquired immunodeficiency syndrome (AIDS) who had cachexia.
Design: Twelve-week, multicenter, randomized, double-blind, placebo-controlled trial.
Setting: Multiple clinical centers.
Patients: 100 patients with AIDS who had weight loss of 10% or more of ideal body weight were randomly assigned to placebo (n = 48) or megestrol acetate (n = 52).
Measurements: Caloric intake, body weight, body composition, and sense of well-being.
Results: Most patients receiving megestrol acetate had increased caloric intake resulting in body weight gain (mainly fat mass). From baseline to week 8, the megestrol acetate group increased their daily caloric intake by 608 calories, whereas the placebo group increased intake by 134 calories (difference, 474 calories; 95% CI, –68 to 880 calories). Body weight in the megestrol acetate group increased by 3.86 kg from baseline to week 8, although it decreased by 0.46 kg in the placebo group (difference, 4.32 kg; CI, 2.42 to 6.22 kg). At week 8 in the megestrol acetate group, patients gained 3.68 kg in fat mass and those in the placebo group lost 0.28 kg (difference, 3.96 kg; CI, 2.49 to 5.43 kg). Body water, lean mass, and patient survival were not statistically different between treatment groups. Patients treated with megestrol acetate had an increased sense of well-being when compared with patients who received placebo.
Conclusions: This megestrol acetate liquid formulation is well tolerated, increases food intake, results in body weight gain, and improves the sense of well-being in cachectic patients with AIDS.
Author and Article Information
From the University of California at Davis, Davis, California; Eisenhower Medical Center, Rancho Mirage, California; Harborview Medical Center, Seattle, Washington; Bristol-Myers Squibb, Plainsboro, New Jersey.
ARTICLE
Megestrol Acetate in Patients with AIDS and Cachexia
Requests for Reprints: Neil M. Flynn, MD, Division of General Medicine, University of California Davis Medical Center, 2221 Stockton Boulevard, PCC Room 3107, Sacramento, CA 95817.
Acknowledgments: The authors thank all of the clinicians, study coordinators, and dietitians who worked on this project. The following clinicians and institutions participated in the megestrol acetate trial: Eric Goosby, MD, and James Kahn, MD (San Francisco General Hospital, San Francisco, California); Patrick Joseph, MD (Peralta Hospital, Oakland, California); Carl Grunfeld, MD, PhD (Veterans Affairs Medical Center, San Francisco, California); Nancy G. Klimas, MD (Veterans Affairs Medical Center, Miami, Florida); Jamie Von Roenn, MD (Northwestern University Medical School, Chicago, Illinois); David L. Cohn, MD (Public Health Department, Denver, Colorado); John Toney, MD (University of South Florida, Tampa, Florida); Donald Armstrong, MD (Memorial Sloan-Kettering Cancer Center, New York, New York); Mark Goldstein, MD (Keith Medical Group, Los Angeles, California); and Dennis Israelski, MD (Veterans Affairs Hospital, Palo Alto, California).
Grant Support: Supported by Bristol-Myers Squibb.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  W. J. Evans Megestrol Acetate Use for Weight Gain Should Be Carefully Considered J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 420 - 421. [Full Text] [PDF]
|
|
|
|
|
|
K. Mulligan, R. Zackin, J. H. Von Roenn, M. A. Chesney, M. J. Egorin, F. R. Sattler, C. A. Benson, T. Liu, T. Umbleja, S. Shriver, et al. Testosterone Supplementation of Megestrol Therapy Does Not Enhance Lean Tissue Accrual in Men with Human Immunodeficiency Virus-Associated Weight Loss: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 563 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cuerda, A. Zugasti, I. Breton, M. Camblor, P. Miralles, and P. Garcia Treatment With Nandrolone Decanoate and Megestrol Acetate in HIV-Infected Men Nutr Clin Pract, February 1, 2005; 20(1): 93 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Lambert, M. G. Flynn, D. H. Sullivan, and W. J. Evans Effects of Megestrol Acetate on Circulating Interleukin-15 and Interleukin-18 Concentrations in Healthy Elderly Men J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2004; 59(8): M855 - M858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dolan, S. Wilkie, N. Aliabadi, M. P. Sullivan, N. Basgoz, B. Davis, and S. Grinspoon Effects of Testosterone Administration in Human Immunodeficiency Virus-Infected Women With Low Weight: A Randomized Placebo-Controlled Study Arch Intern Med, April 26, 2004; 164(8): 897 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Lennie Sex Differences in Severity of Inflammation-Induced Anorexia and Weight Loss Biol Res Nurs, April 1, 2004; 5(4): 255 - 264. [Abstract] [PDF]
|
|
|
|
|
|
C. P. Lambert, D. H. Sullivan, and W. J. Evans Megestrol Acetate-Induced Weight Gain Does Not Negatively Affect Blood Lipids in Elderly Men: Effects of Resistance Training and Testosterone Replacement J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2003; 58(7): M644 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Lambert, D. H. Sullivan, and W. J. Evans Effects of Testosterone Replacement and/or Resistance Training on Interleukin-6, Tumor Necrosis Factor Alpha, and Leptin in Elderly Men Ingesting Megestrol Acetate: A Randomized Controlled Trial J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2003; 58(2): M165 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Gomez, P. Ruiz, R. Lopez, and C. Rivera Treatment with Megestrol Acetate Improves Human Immunodeficiency Virus-Associated Immune Thrombocytopenia Clin. Vaccine Immunol., May 1, 2002; 9(3): 583 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Lambert, D. H. Sullivan, S. A. Freeling, D. M. Lindquist, and W. J. Evans Effects of Testosterone Replacement and/or Resistance Exercise on the Composition of Megestrol Acetate Stimulated Weight Gain in Elderly Men: A Randomized Controlled Trial J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2100 - 2106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Weisberg, J. Wanger, J. Olson, B. Streit, C. Fogarty, T. Martin, and R. Casaburi Megestrol Acetate Stimulates Weight Gain and Ventilation in Underweight COPD Patients* Chest, April 1, 2002; 121(4): 1070 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-s. Yeh, S.-y. Wu, D. M. Levine, T. S. Parker, J. S. Olson, M. R. Stevens, and M. W. Schuster The Correlation of Cytokine Levels With Body Weight After Megestrol Acetate Treatment in Geriatric Patients J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2001; 56(1): 48M - 54. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Fox-Wheeler, L. Heller, C. M. Salata, F. Kaufman, M. L. Loro, V. Gilsanz, M. Haight, G. C. Umman, N. Barton, and J. A. Church Evaluation of the Effects of Oxandrolone on Malnourished HIV-Positive Pediatric Patients Pediatrics, December 1, 1999; 104(6): 73e - 73. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. E. Finucane, C. Christmas, and K. Travis Tube Feeding in Patients With Advanced Dementia: A Review of the Evidence JAMA, October 13, 1999; 282(14): 1365 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-S. Yeh and M. W Schuster Geriatric cachexia: the role of cytokines Am. J. Clinical Nutrition, August 1, 1999; 70(2): 183 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Corcoran and S. Grinspoon Treatments for Wasting in Patients with the Acquired Immunodeficiency Syndrome N. Engl. J. Med., June 3, 1999; 340(22): 1740 - 1750. [Full Text] [PDF]
|
|
|
|
|
|
A. Strawford, T. Barbieri, M. Van Loan, E. Parks, D. Catlin, N. Barton, R. Neese, M. Christiansen, J. King, and M. K. Hellerstein Resistance Exercise and Supraphysiologic Androgen Therapy in Eugonadal Men With HIV-Related Weight Loss: A Randomized Controlled Trial JAMA, April 14, 1999; 281(14): 1282 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jain, D. W. Golde, R. Bailey, and M. E. Geffner Insulin-Like Growth Factor-I Resistance Endocr. Rev., October 1, 1998; 19(5): 625 - 646. [Abstract] [Full Text]
|
|
|
|
|
|
S. Bhasin, T. W. Storer, N. Asbel-Sethi, A. Kilbourne, R. Hays, I. Sinha-Hikim, R. Shen, S. Arver, and G. Beall Effects of Testosterone Replacement with a Nongenital, Transdermal System, Androderm, in Human Immunodeficiency Virus-Infected Men with Low Testosterone Levels J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3155 - 3162. [Abstract] [Full Text]
|
|
|
|
|
|
K. Miller, C. Corcoran, C. Armstrong, K. Caramelli, E. Anderson, D. Cotton, N. Basgoz, L. Hirschhorn, R. Tuomala, D. Schoenfeld, et al. Transdermal Testosterone Administration in Women with Acquired Immunodeficiency Syndrome Wasting: A Pilot Study J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2717 - 2725. [Abstract] [Full Text]
|
|
|
|
|
|
K. Mulligan, V. W. Tai, and M. Schambelan Effects of Chronic Growth Hormone Treatment on Energy Intake and Resting Energy Metabolism in Patients with Human Immunodeficiency Virus-Associated Wasting--A Clinical Research Center Study J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1542 - 1547. [Abstract] [Full Text]
|
|
|
|
|
|
P. Pertel and M. Till Intractable Hiccups Induced by the Use of Megestrol Acetate Arch Intern Med, April 13, 1998; 158(7): 809 - 810. [Full Text] [PDF]
|
|
|
|
|
|
R. H. Clarick, W. A. Hanekom, R. Yogev, and E. G. Chadwick Megestrol Acetate Treatment of Growth Failure in Children Infected With Human Immunodeficiency Virus Pediatrics, March 1, 1997; 99(3): 354 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The HIV Wasting Syndrome AIDS Clinical Care, November 1, 1996; 1996(1101): 1 - 1. [Full Text]
|
|
|
|
 |
|
 MEGESTROL FOR AIDS-RELATED CACHEXIA Journal Watch (General), September 23, 1994; 1994(923): 1 - 1. [Full Text]
|
|
Article
